CIK 1535610
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 61.69% | 7 |
| Pharmaceuticals & Biotechnology | 20.43% | 8 |
| Chemicals | 6.28% | 1 |
| Commercial Services & Supplies | 4.23% | 1 |
| Oil, Gas & Consumable Fuels | 2.77% | 1 |
| Metals & Mining | 2.63% | 1 |
| Health Care Equipment & Supplies | 1.82% | 2 |
| Professional Services | 0.15% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | SPY | STATE STR SPDR S&P 500 ETF T | Unclassified | 31.13% |
| 2 | ALP | ALPHATON CAPITAL CORP | Unclassified | 11.46% |
| 3 | BCTXL | BRIACELL THERAPEUTICS CORP | Unclassified | 6.87% |
| 4 | SNES | SenesTech, Inc. | Materials | 6.28% |
| 5 | DSY | BIG TREE CLOUD HLDGS LTD | Unclassified | 5.90% |
| 6 | BCTX | BriaCell Therapeutics Corp. | Health Care | 5.42% |
| 7 | TC | Token Cat Ltd | Industrials | 4.23% |
| 8 | CPOP | POP CULTURE GROUP CO LTD | Unclassified | 3.52% |
| 9 | MBRX | Moleculin Biotech, Inc. | Health Care | 3.01% |
| 10 | BDRX | Biodexa Pharmaceuticals Plc | Health Care | 2.79% |
15/22 names classified · sector 38.3% of weight · industry 38.3% · mkt cap 29.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 38.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/22 names) · unclassified 100.0%: SPY, ALP, BCTXL, SNES, DSY, BCTX, TC, CPOP, MBRX, BDRX +12 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | SPYSTATE STR SPDR S&P 500 ETF T | 2,734 | $2M | 31.1% | ADD 716% |
| 2 | ALPALPHATON CAPITAL CORP | 2,072,103 | $654,785 | 11.5% | NEW |
| 3 | BCTXLBRIACELL THERAPEUTICS CORP | 380,686 | $392,145 | 6.9% | NEW |
| 4 | SNESSENESTECH INC | 218,533 | $358,394 | 6.3% | ADD 4% |
| 5 | DSYBIG TREE CLOUD HLDGS LTD | 137,611 | $337,147 | 5.9% | NEW |
| 6 | BCTXBRIACELL THERAPEUTICS CORP | 73,915 | $309,704 | 5.4% | NEW |
| 7 | TCTOKEN CAT LTD | 23,239 | $241,686 | 4.2% | NEW |
| 8 | CPOPPOP CULTURE GROUP CO LTD | 664,449 | $201,129 | 3.5% | TRIM −31% |
| 9 | MBRXMOLECULIN BIOTECH INC | 75,021 | $171,798 | 3.0% | NEW |
| 10 | BDRXBIODEXA PHARMACEUTICALS PLC | 257,472 | $159,092 | 2.8% | ADD 35% |
| 11 | RKDAARCADIA BIOSCIENCES INC | 114,554 | $158,085 | 2.8% | NEW |
| 12 | TRXTRX GOLD CORPORATION | 100,000 | $150,000 | 2.6% | NEW |
| 13 | INMINMED PHARMACEUTICALS INC | 220,260 | $142,046 | 2.5% | ADD 9% |
| 14 | CANFCAN FITE BIOFARMA LTD | 42,559 | $131,933 | 2.3% | NEW |
| 15 | SXTCCHINA SXT PHARMACEUTICALS IN | 78,170 | $131,326 | 2.3% | NEW |
| 16 | REVBREVELATION BIOSCIENCES INC | 99,432 | $119,318 | 2.1% | NEW |
| 17 | CLDICALIDI BIOTHERAPEUTICS INC | 434,903 | $103,855 | 1.8% | NEW |
| 18 | BJDXBLUEJAY DIAGNOSTICS INC | 28,726 | $52,856 | 0.9% | NEW |
| 19 | LYRALYRA THERAPEUTICS INC | 104,059 | $51,103 | 0.9% | TRIM −41% |
| 20 | TPSTTEMPEST THERAPEUTICS INC | 17,856 | $29,284 | 0.5% | TRIM −90% |
| 21 | BCTXZBRIACELL THERAPEUTICS CORP | 206,753 | $28,945 | 0.5% | TRIM −22% |
| 22 | BNBXBNB PLUS CORP | 13,541 | $8,666 | 0.2% | TRIM −75% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| SPYSTATE STR SPDR S&P 500 ETF T | 3K | 1K | — | — | 335 | 3K | $2M |
| ALPALPHATON CAPITAL CORP | — | — | — | — | — | 2.1M | $654,785 |
| BCTXLBRIACELL THERAPEUTICS CORP | — | — | — | — | — | 381K | $392,145 |
| SNESSENESTECH INC | — | — | — | 71K | 211K | 219K | $358,394 |
| DSYBIG TREE CLOUD HLDGS LTD | — | — | — | — | — | 138K | $337,147 |
| BCTXBRIACELL THERAPEUTICS CORP | — | — | — | — | — | 74K | $309,704 |
| TCTOKEN CAT LTD | — | — | — | 4K | — | 23K | $241,686 |
| CPOPPOP CULTURE GROUP CO LTD | — | — | — | 1.2M | 957K | 664K | $201,129 |
| MBRXMOLECULIN BIOTECH INC | — | — | — | — | — | 75K | $171,798 |
| BDRXBIODEXA PHARMACEUTICALS PLC | — | — | — | — | 191K | 257K | $159,092 |
| RKDAARCADIA BIOSCIENCES INC | — | — | — | — | — | 115K | $158,085 |
| TRXTRX GOLD CORPORATION | — | — | — | — | — | 100K | $150,000 |
| INMINMED PHARMACEUTICALS INC | — | — | — | 220K | 202K | 220K | $142,046 |
| CANFCAN FITE BIOFARMA LTD | — | — | — | — | — | 43K | $131,933 |
| SXTCCHINA SXT PHARMACEUTICALS IN | — | — | — | — | — | 78K | $131,326 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
